Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dipexium IS DEAD and it worths 0.
Nobody says anything? ... What happened with the results?
When will they they release the phase 3 top data results?
RIP GALT
I think it will be tonight.
i'm holding the stock. If results good it would be a x3-10.
But the company registered the patent in EU and Japan. When they release the data the stock price x2.
New buyin for 5.5 billion 40 minutes ago.
Very strange. May be this week ...
Yes very strange no results yet. BUt the question is : Did they say they are going to release phase III data September 2016?
where are the fuckin phase 3 results?
Im thinking about the same thing ... What happened to phase III?
No results today yet ...
Locilex could belong to a very interesting antibiotic new familiy.
There is no topical antibotic that works on gram positive and negative. Fusidic acid and Mupirocin only on gram positives.
Topical Locilex performance is very similar to ofloxacin oral in pseudomona and another gram negative.
The advantage is the topical way is safest than a quinolon oral administration and no achilles tendon rupture risk with Locilex.
I think Locilex is a very useful drug for skin infections with gram negative coverage and a new antibiotic family for discover.
Im would like to see the phase III today. IF good the company could x 100% its capital market.
What about Locilex phase III Trial?
Phase II Trial or Phase II Trolling?
I will keep on Galectin the following months but with my money out. Everybody bet against GALT but there is very little chance in March of success. Obviosuly GALT wont acquire 5 billion capital market in one session. If success i would buy, but not before results. NOT BEFORE.
There is a little chance of success due to these points (all together).
1.MRI has less sentivity than Hepatic Biopsia (no radiologic changes but yes histologic)
2. The human metabolism is quite slower than rats. Probably more time would be needed.
3. Rats dont eat trash food with a lot of sugar and additives. People in trial had more than a beer in the last 12 weeks and contaminated food (all food is contaminated).
Phase I was a fake only for earn money or real?
Phase II doesn't work.probably due to three points above ... but if it works on rats, what about veterinary use?
I would reinforce one trial arm with human and restriction dietethic until Dec 2017 at x10 the dose
Other trial arm should be focused to veterinary use.
Sell now or die tomorrow.
Buy? mmm what?
But there is a very little chance to success:
1. MRI has less sensitivity than hepatic biopsia.
+
2. Rat metabolism is much quicker than human. May be more time of treatment and higher dosages could provide any benefit.
Until December 2017 there wont be any impact notice. RIP GALT.
Galectin is rubbish. You can't cure hepatic cirrosis with food adittives derivated. We eat a lot of rubbish daily that cause esteatohepatitis and contain these additives derivated.
Galectin is dead.
Galectin now worths near 0$
Where can i see the conference call?
NO NEW RESULTS UNTIL DEC 2017.
Im out since 2 days ago hehehe. I bet for ARRY yesterday and i recovered part of loses. Today i didn't play. If results would be good there is time for up and up . Now time to lose hahaha...
Thanks for trolling Biotech for the technical study. You opened my eyes.
Would they publish their trial results 28,29 or 30? Q32016 ends this Friday.
If they developed a good stuff for all these diseases the potential market would be about 50 billions.
Simtuzumab is an inmunomodulator. It works on CD inmune receptors and it would cause possible inmunosupression as side effect.
Galectin is working on a glucopeptyde that works without inmunosupression and thus, less side effects.
I got 1500 stocks ready for love last Friday. Skyrocket in 3, 2, 1 ... .
I already have my seat.